Journey to anticoagulant access following payer rejection of apixaban.

Deitelzweig, Steven; Xie, Lin; Terasawa, Emi; Hood, David Weber; Cato, Matthew; Atreja, Nipun; Kang, Amiee; Hines, Dionne M

Deitelzweig, Steven; Xie, Lin; Terasawa, Emi; Hood, David Weber; Cato, Matthew; Atreja, Nipun; Kang, Amiee; Hines, Dionne M.

Affiliation

Deitelzweig S; Ochsner Health, 1514 Jefferson Hwy, New Orleans, LA 70121. Email: sdeitelzweig@ochsner.org.

Am J Manag Care ; 29(11): e330-e338, 2023 11 01.

Article in En | MEDLINE | ID: mdl-37948653

Subject(s)

Atrial Fibrillation; Stroke; Humans; Male; United States; Female; Anticoagulants/therapeutic use; Retrospective Studies; Pyrazoles/therapeutic use; Pyridones/therapeutic use; Stroke/drug therapy; Atrial Fibrillation/drug therapy; Atrial Fibrillation/complications; Administration, Oral

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Atrial Fibrillation / Stroke Limits: Female / Humans / Male Country/Region as subject: America do norte Language: En Journal: Am J Manag Care Journal subject: SERVICOS DE SAUDE Year: 2023 Type: Article

Fulltext

XML

PubMed Links

Search on Google